Both in R&D — Physical & Biological Sciences
IB Acquisition vs Absci
Over the past year IBAC returned +3.7% and ABSI returned +169.9%; their daily moves had a correlation of 0.04.
IBAC +3.7% ABSI +169.9%Growth of $1, one year, split-adjusted
| Metric | IBAC | ABSI |
|---|---|---|
| Price | $10.81 | $9.47 |
| Market cap | $54.1M | $1.63B |
| Today | −0.46% | −9.64% |
| 1 month | −0.6% | +2.7% |
| 6 months | −0.2% | +64.7% |
| Year to date | +3.0% | +171.3% |
| 1 year | — | +140.4% |
| Revenue growth (YoY) | — | −46.4% |
| Gross margin | — | 100.0% |
| Net margin | — | −10443.4% |
| P/E (TTM) | — | — |
| Price / sales | — | 1,041.1× |
| Net cash | — | $201.0M |
| Dividend yield | — | — |
| Volatility (60d) | 20.1% | 102.8% |
| Short % of float | 0.3% | 31.0% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).